Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Acquisitions (2016 - 2023)

Bio-Techne (TECH) has 10 years of Acquisitions data on record, last reported at $3.3 million in Q4 2023.

  • For Q4 2023, Acquisitions changed N/A year-over-year to $3.3 million; the TTM value through Mar 2025 reached $3.3 million, down 98.07%, while the annual FY2024 figure was $169.7 million, 67.72% up from the prior year.
  • Acquisitions reached $3.3 million in Q4 2023 per TECH's latest filing, down from $166.4 million in the prior quarter.
  • Across five years, Acquisitions topped out at $215.6 million in Q2 2021 and bottomed at -$1000.0 in Q1 2019.
  • Average Acquisitions over 4 years is $83.9 million, with a median of $59.2 million recorded in 2019.
  • The widest YoY moves for Acquisitions: up 517.81% in 2019, down 100.0% in 2019.
  • A 4-year view of Acquisitions shows it stood at $17.2 million in 2019, then soared by 1152.98% to $215.6 million in 2021, then plummeted by 53.07% to $101.2 million in 2022, then plummeted by 96.76% to $3.3 million in 2023.
  • Per Business Quant database, its latest 3 readings for Acquisitions were $3.3 million in Q4 2023, $166.4 million in Q3 2023, and $101.2 million in Q3 2022.